272 related articles for article (PubMed ID: 8107865)
1. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution.
Zhang F; Strand A; Robbins D; Cobb MH; Goldsmith EJ
Nature; 1994 Feb; 367(6465):704-11. PubMed ID: 8107865
[TBL] [Abstract][Full Text] [Related]
2. Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5'-triphosphate.
Robinson MJ; Harkins PC; Zhang J; Baer R; Haycock JW; Cobb MH; Goldsmith EJ
Biochemistry; 1996 May; 35(18):5641-6. PubMed ID: 8639522
[TBL] [Abstract][Full Text] [Related]
3. Structure of GSK3beta reveals a primed phosphorylation mechanism.
ter Haar E; Coll JT; Austen DA; Hsiao HM; Swenson L; Jain J
Nat Struct Biol; 2001 Jul; 8(7):593-6. PubMed ID: 11427888
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
[TBL] [Abstract][Full Text] [Related]
5. Influence of a mutation in the ATP-binding region of Ca2+/calmodulin-dependent protein kinase II on its interaction with peptide substrates.
Praseeda M; Pradeep KK; Krupa A; Krishna SS; Leena S; Kumar RR; Cheriyan J; Mayadevi M; Srinivasan N; Omkumar RV
Biochem J; 2004 Mar; 378(Pt 2):391-7. PubMed ID: 14558884
[TBL] [Abstract][Full Text] [Related]
6. Modelling of active forms of protein kinases: p38--a case study.
Ginalski K; Lesyng B; Sowadski J; Wojciechowski M
Acta Biochim Pol; 1997; 44(3):557-64. PubMed ID: 9511965
[TBL] [Abstract][Full Text] [Related]
7. Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme.
Rosenberg OS; Deindl S; Sung RJ; Nairn AC; Kuriyan J
Cell; 2005 Dec; 123(5):849-60. PubMed ID: 16325579
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
Beadling C; Ng J; Babbage JW; Cantrell DA
EMBO J; 1996 Apr; 15(8):1902-13. PubMed ID: 8617237
[TBL] [Abstract][Full Text] [Related]
9. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
Pettiford SM; Herbst R
Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
[TBL] [Abstract][Full Text] [Related]
10. Activity of the MAP kinase ERK2 is controlled by a flexible surface loop.
Zhang J; Zhang F; Ebert D; Cobb MH; Goldsmith EJ
Structure; 1995 Mar; 3(3):299-307. PubMed ID: 7540485
[TBL] [Abstract][Full Text] [Related]
11. The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.
Akella R; Min X; Wu Q; Gardner KH; Goldsmith EJ
Structure; 2010 Dec; 18(12):1571-8. PubMed ID: 21134636
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of MAP kinase (ERK1/ERK2) activity by phosphorylated glia maturation factor (GMF).
Zaheer A; Lim R
Biochemistry; 1996 May; 35(20):6283-8. PubMed ID: 8639570
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of the catalytic domain of human protein kinase associated with apoptosis and tumor suppression.
Tereshko V; Teplova M; Brunzelle J; Watterson DM; Egli M
Nat Struct Biol; 2001 Oct; 8(10):899-907. PubMed ID: 11573098
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen exchange solvent protection by an ATP analogue reveals conformational changes in ERK2 upon activation.
Lee T; Hoofnagle AN; Resing KA; Ahn NG
J Mol Biol; 2005 Oct; 353(3):600-12. PubMed ID: 16185715
[TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition of MAP kinase activation by a peptide representing the alpha C helix of ERK.
Horiuchi KY; Scherle PA; Trzaskos JM; Copeland RA
Biochemistry; 1998 Jun; 37(25):8879-85. PubMed ID: 9636029
[TBL] [Abstract][Full Text] [Related]
16. Identification of substrate orienting and phosphorylation sites within tryptophan hydroxylase using homology-based molecular modeling.
Jiang GC; Yohrling GJ; Schmitt JD; Vrana KE
J Mol Biol; 2000 Sep; 302(4):1005-17. PubMed ID: 10993738
[TBL] [Abstract][Full Text] [Related]
17. Activation of calcium/calmodulin regulated kinases.
Wilmann M; Gautel M; Mayans O
Cell Mol Biol (Noisy-le-grand); 2000 Jul; 46(5):883-94. PubMed ID: 10976872
[TBL] [Abstract][Full Text] [Related]
18. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins.
Gopalbhai K; Meloche S
J Cell Physiol; 1998 Jan; 174(1):35-47. PubMed ID: 9397154
[TBL] [Abstract][Full Text] [Related]
19. Crystallization and preliminary X-ray studies of extracellular signal-regulated kinase-2/MAP kinase with an incorporated His-tag.
Zhang F; Robbins DJ; Cobb MH; Goldsmith EJ
J Mol Biol; 1993 Oct; 233(3):550-2. PubMed ID: 8411162
[TBL] [Abstract][Full Text] [Related]
20. Docking interactions induce exposure of activation loop in the MAP kinase ERK2.
Zhou T; Sun L; Humphreys J; Goldsmith EJ
Structure; 2006 Jun; 14(6):1011-9. PubMed ID: 16765894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
